Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 32 peer-reviewed journal articles Updated
Neurology · Focal Epilepsy

Are Focal Epilepsy Meds Safe in Pregnancy & Breastfeeding?

At a Glance

For focal sensory epilepsy, lamotrigine, levetiracetam, and oxcarbazepine have comparatively lower observed pregnancy risks, but no medicine is safest for everyone. Do not stop treatment; a neurologist should balance seizure control, drug levels, birth control, and breastfeeding exposure.

If you have focal sensory epilepsy, family planning requires careful coordination between you, your neurologist, and your obstetrician. The anti-seizure medications (ASMs) with comparatively lower observed pregnancy risks are generally lamotrigine, levetiracetam, and oxcarbazepine [1][2]. Medications like valproate (valproic acid) and topiramate are linked to higher rates of birth defects and developmental delays, and are generally avoided if possible [3][4]. However, the safest medication is always the one that effectively controls your seizures while minimizing side effects [5]. You should never switch medications solely because of a pregnancy without a specialist-supervised plan, as uncontrolled seizures carry severe risks [6][3].

Birth Control and Medication Interactions

If you are preventing pregnancy, your birth control and epilepsy medications must be compatible. Interactions can go in both directions:

  • Medications reducing birth control effectiveness: Enzyme-inducing ASMs (such as carbamazepine, oxcarbazepine, phenytoin, phenobarbital, primidone, and high-dose topiramate) speed up how fast your body processes hormones [7][8]. This can make the pill, patch, ring, contraceptive implant, progestin-only pills, and even emergency contraception fail [9][10].
  • Birth control reducing medication effectiveness: Estrogen (found in combined pills, patches, and rings) can significantly lower blood levels of lamotrigine, increasing your risk of a seizure [11][12]. Furthermore, when you take the inactive “placebo” week of pills—or if you stop the birth control entirely—your lamotrigine levels can rapidly spike, causing severe side effects or toxicity [13].

Because of these complex interactions, many specialists recommend highly effective, non-interacting methods like intrauterine devices (IUDs) or the depo injection, along with a pharmacist-guided backup plan [14][15].

Preconception Planning: Before You Get Pregnant

The best time to prepare for a healthy pregnancy is well before you conceive. People with excellent seizure control before pregnancy are significantly more likely to remain seizure-free throughout gestation [6].

  • Optimize your medication: Your doctor will aim to use the lowest effective dose of a single medication (monotherapy) if possible [2].
  • Establish a baseline blood level: Your doctor may check your “trough” level (the lowest level of drug in your blood, right before your next dose) while you are healthy to use as a baseline for comparison later [16].
  • Take folic acid: Guidelines recommend that people taking ASMs consume at least 0.4 mg of folic acid daily [3]. While some experts recommend higher doses (1–2 mg or more) for those on specific drugs like valproate, higher doses are not universally standardized. You should not self-prescribe high-dose supplements; instead, ask your neurologist for an individualized prescription [17].

The Danger of Stopping Medication Suddenly

If you discover you are pregnant, do not stop taking your medication or lower your dose on your own [3]. Abruptly stopping can trigger uncontrolled seizures or status epilepticus (a prolonged, life-threatening seizure emergency) [18][19]. While brief focal aware sensory seizures pose less immediate danger to a fetus, a seizure that spreads to become a generalized convulsive seizure restricts oxygen, risks severe physical injury, and increases the risk of fetal death [20][19].

Emergency Action Plan: Seek emergency medical help if a seizure lasts 5 minutes or longer, if repeated seizures occur without recovery in between, if there is difficulty breathing, or if serious injury occurs [21].

Monitoring During Pregnancy

During pregnancy, your body’s blood volume expands and your kidneys clear drugs faster. Because of this, blood concentrations of medications like lamotrigine, levetiracetam, oxcarbazepine (measured via its active metabolite), and topiramate often drop [16][22].

Your care team will likely use therapeutic drug monitoring to track these changes [16]. However, not every medication has a universal “target” level, and dose increases are not automatic just because a lab number drops [23]. Your doctor will adjust your dose based on your lab results, your pre-pregnancy baseline, and whether you are experiencing aura symptoms or side effects [22].

Labor, Delivery, and Postpartum Care

  • During Labor: Take your prescribed ASMs during labor. If vomiting prevents you from keeping medication down, inform the hospital staff so they can provide an alternative route.
  • Postpartum Adjustments: After delivery, your body quickly returns to its pre-pregnancy state [24]. If your medication dose was increased during pregnancy, leaving it at that high dose can cause postpartum toxicity (dizziness, double vision, excessive sedation). Your neurologist should provide a planned, supervised postpartum adjustment schedule [25].
  • Newborn Safety: Sleep deprivation in the weeks after birth is a major seizure trigger. Enlist help for nighttime feedings, and avoid bathing the baby alone or carrying the infant while walking on hard surfaces if you are at risk of a seizure [26].

Breastfeeding

Breastfeeding is generally supported and encouraged for parents taking anti-seizure medications [27]. While medicines do pass into breast milk, the amount the infant absorbs varies significantly by drug:

  • Infant blood levels typically remain very low for carbamazepine, levetiracetam, oxcarbazepine, and valproate [28][29].
  • Levels can be higher for lamotrigine and topiramate [30].

Always monitor your baby closely for signs of excessive sleepiness (sedation), poor feeding, inadequate weight gain, jaundice, or rash [31][32]. If you notice these signs, contact your pediatrician. If breastfeeding feels overwhelming or if infant side effects occur, combination feeding or formula are completely acceptable and safe alternatives.

Common questions in this guide

Which focal epilepsy medicines are usually considered lower risk during pregnancy?
Lamotrigine, levetiracetam, and oxcarbazepine have comparatively lower observed pregnancy risks than some other anti-seizure medicines. The right choice depends on which medicine controls your seizures and your side effects, so do not change treatment without a neurologist’s plan.
Is breastfeeding possible while I take an anti-seizure medicine?
Breastfeeding is generally supported for people taking anti-seizure medicines, but the amount reaching the infant varies by drug. Infant blood levels are usually low with carbamazepine, levetiracetam, oxcarbazepine, and valproate, while levels may be higher with lamotrigine and topiramate. Ask your pediatrician what to watch for, including unusual sleepiness, poor feeding, poor weight gain, jaundice, or rash.
What should I do with my seizure medicine after a positive pregnancy test?
Do not stop or lower the dose on your own. Sudden changes can cause uncontrolled seizures or status epilepticus, and a generalized convulsive seizure can cause serious injury and reduce oxygen reaching the fetus. Contact your neurologist promptly for a supervised plan.
Can my epilepsy medicine make birth control less effective?
Yes. Enzyme-inducing medicines such as carbamazepine, oxcarbazepine, phenytoin, phenobarbital, primidone, and high-dose topiramate can reduce the effectiveness of hormonal contraception and some emergency contraception. Estrogen-containing pills, patches, and rings can lower lamotrigine levels, so a neurologist or pharmacist should help choose contraception and manage any backup plan.
How are anti-seizure medicine doses monitored during pregnancy?
Pregnancy can increase blood volume and kidney clearance, causing levels of medicines such as lamotrigine, levetiracetam, oxcarbazepine’s active metabolite, and topiramate to fall. Clinicians may compare blood tests with a pre-pregnancy lowest pre-dose level and consider seizure symptoms and side effects; a lower lab value does not automatically mean the dose should rise.
How can I reduce seizure and newborn safety risks after delivery?
Your neurologist should give you a planned, supervised schedule to adjust any dose increased during pregnancy because drug levels can rebound after delivery. Protect sleep, get help with nighttime care, and avoid bathing or carrying the baby alone if you could have a seizure. During breastfeeding, watch the baby for excessive sleepiness, poor feeding, poor weight gain, jaundice, or rash and contact the pediatrician if these occur.
How much folic acid should I take before pregnancy if I have epilepsy?
Guidelines recommend at least 0.4 mg of folic acid daily for people taking anti-seizure medicines, while some people may be prescribed 1 to 2 mg or more depending on the medication. Ask your neurologist for an individualized dose and do not start high-dose folic acid on your own.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Related questions

What Do EEG Results Mean in Focal Sensory Seizures? How Can You Tell Focal Sensory Seizures From Panic and FND? How Long Do Focal Sensory Seizures Last? Recovery Explained How Is the Best Medicine Chosen for Focal Sensory Seizures? Can Focal Sensory Seizures Cause Permanent Brain Damage?
Show more
What Blood Tests Are Used for Focal Sensory Seizures? What Does Epilepsy-Protocol MRI Look For in Focal Epilepsy? When Should a Normal EEG Be Repeated for Focal Seizures? How Long Until Focal Sensory Seizure Medications Work? Can Partial Sensory Epilepsy Cause Nocturnal Seizures? Why You Can Stay Aware During a Focal Sensory Seizure? What Are Focal Sensory Seizure Medication Side Effects? What Happens During Ambulatory or Inpatient Video EEG? What If Medication Partly Controls Focal Sensory Seizures? How Are Focal Sensory Seizures Diagnosed? EEG and MRI What Causes Focal Sensory Epilepsy? Genes or Brain Lesions? What to Record in a Focal Sensory Seizure Diary or Video? Can Focal Sensory Seizures Become Full-Body Seizures? Does One Focal Sensory Seizure Mean I Have Epilepsy?

Get notified when new evidence is published on partial sensory epilepsy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific anti-seizure medication options have the lowest risks for my specific type of focal sensory epilepsy?
  2. 2.Should we establish a baseline trough blood concentration of my current medication before I attempt to conceive?
  3. 3.How will my current or planned birth control interact with my specific epilepsy medication and dose?
  4. 4.What is our explicit plan and timeline for checking my blood levels during pregnancy?
  5. 5.What is my exact, individualized postpartum plan for safely reducing my medication dose to avoid toxicity?
  6. 6.What specific emergency action plan should my family follow if I have a prolonged or generalized convulsive seizure?

References

References (32)
  1. 1

    Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy.

    Battino D, Tomson T, Bonizzoni E, et al.

    JAMA neurology 2024; (81(5)):481-489 doi:10.1001/jamaneurol.2024.0258.

    PMID: 38497990
  2. 2

    Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication.

    Pack AM, Oskoui M, Roberson SW, et al.

    Epilepsy currents 2026; (26(1)):64-84 doi:10.1177/15357597241258514.

    PMID: 40083742
  3. 3

    Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM.

    Pack AM, Oskoui M, Williams Roberson S, et al.

    Neurology 2024; (102(11)):e209279 doi:10.1212/WNL.0000000000209279.

    PMID: 38748979
  4. 4

    Safety of Valproic Acid Use in Pregnant Women: A Systematic Review and Meta-Analysis.

    Yang X, Sun Y, Hua Z, et al.

    The journal of obstetrics and gynaecology research 2025; (51(11)):e70121 doi:10.1111/jog.70121.

    PMID: 41161707
  5. 5

    Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.

    Nevitt SJ, Tudur Smith C, Weston J, Marson AG

    The Cochrane database of systematic reviews 2018; (6()):CD001031 doi:10.1002/14651858.CD001031.pub4.

    PMID: 29952431
  6. 6

    Epileptic seizure control during and after pregnancy in Australian women.

    Vajda FJE, O'Brien TJ, Graham JE, et al.

    Acta neurologica Scandinavica 2022; (145(6)):730-736 doi:10.1111/ane.13609.

    PMID: 35257362
  7. 7

    Effect of early tolerability and co-medication on long-term perampanel treatment outcomes in real-world settings.

    You HL, Park J, Koo YS

    Clinical neurology and neurosurgery 2026; (266()):109411 doi:10.1016/j.clineuro.2026.109411.

    PMID: 41887000
  8. 8

    The intersection of epilepsy and assisted reproduction: A review of therapeutic approaches and considerations.

    Mohammadi B, Mehvari J, Naghibi N, Tabrizi N

    Seizure 2025; (133()):219-223 doi:10.1016/j.seizure.2025.10.019.

    PMID: 41197258
  9. 9

    Pharmacokinetic Considerations with the Use of Antiepileptic Drugs in Patients with HIV and Organ Transplants.

    Asconapé JJ

    Current neurology and neuroscience reports 2018; (18(12)):89 doi:10.1007/s11910-018-0897-4.

    PMID: 30302572
  10. 10

    Inconsistent reporting of drug-drug interactions for hormonal contraception and antiepileptic drugs - Implications for reproductive health for women with epilepsy.

    Decker BM, Acton EK, Davis KA, Willis AW

    Epilepsy & behavior : E&B 2021; (114(Pt A)):107626 doi:10.1016/j.yebeh.2020.107626.

    PMID: 33309232
  11. 11

    Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.

    Serafini A, Gerard E, Genton P, et al.

    CNS drugs 2019; (33(3)):195-208 doi:10.1007/s40263-018-00602-2.

    PMID: 30747367
  12. 12

    Interactions between antiseizure medications and contraception: A study about the knowledge of patients and their specialist physicians.

    Gosset A, Denuelle M, Valton L, et al.

    Epilepsy & behavior : E&B 2022; (129()):108627 doi:10.1016/j.yebeh.2022.108627.

    PMID: 35240507
  13. 13

    Contraceptive management in people with epilepsy: A narrative review of drug interactions, special populations, and clinical guidance.

    Al-Faraj AO, Woodrich N, Kirkpatrick L, et al.

    Epileptic disorders : international epilepsy journal with videotape 2026; (28(4)):1021-1032 doi:10.1002/epd2.70205.

    PMID: 41841321
  14. 14

    A Review of Concordance and Quality in Clinical Guidelines for Hormonal Contraceptives to Mitigate Drug-Drug Interactions in Women With Epilepsy.

    Muschett MR, Ewig C, Morris E, et al.

    Pharmacoepidemiology and drug safety 2024; (33(8)):e5861 doi:10.1002/pds.5861.

    PMID: 39090796
  15. 15

    Counseling by epileptologists affects contraceptive choices of women with epilepsy.

    Espinera AR, Gavvala J, Bellinski I, et al.

    Epilepsy & behavior : E&B 2016; (65()):1-6 doi:10.1016/j.yebeh.2016.08.021.

    PMID: 27829186
  16. 16

    Therapeutic Drug Monitoring of Antiepileptic Drugs in Women with Epilepsy Before, During, and After Pregnancy.

    Arfman IJ, Wammes-van der Heijden EA, Ter Horst PGJ, et al.

    Clinical pharmacokinetics 2020; (59(4)):427-445 doi:10.1007/s40262-019-00845-2.

    PMID: 31912315
  17. 17

    Folate supplement dosage for pregnant people with epilepsy: Survey of international experts recommendation and current practices.

    Li Y, Bromley R, Meador KJ, et al.

    Epileptic disorders : international epilepsy journal with videotape 2025; (27(6)):1209-1216 doi:10.1002/epd2.70097.

    PMID: 40884533
  18. 18

    Rethinking the classification of acute status epilepticus: structural brain vs. systemic etiologies.

    Xhepa S, Gullino P, De Stefano P

    Frontiers in neurology 2026; (17()):1763224 doi:10.3389/fneur.2026.1763224.

    PMID: 41641328
  19. 19

    Association of seizure control during pregnancy with adverse offspring outcomes in women with epilepsy.

    Fu Y, Shi F, Sha L, et al.

    Journal of neurology, neurosurgery, and psychiatry 2025; (96(7)):621-629 doi:10.1136/jnnp-2024-335751.

    PMID: 40175068
  20. 20

    Effects of antiseizure medication withdrawal during the first trimester of pregnancy on seizure control and offspring outcomes.

    Fu Y, Shi F, Sha L, et al.

    Epilepsia 2024; (65(11)):3186-3198 doi:10.1111/epi.18125.

    PMID: 39287982
  21. 21

    Management of status epilepticus in pregnancy: a clinician survey.

    Swor D, Juneja P, Constantine C, et al.

    Neurological research and practice 2024; (6(1)):3 doi:10.1186/s42466-023-00295-z.

    PMID: 38233889
  22. 22

    Antiseizure Medication Concentrations During Pregnancy: Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study.

    Pennell PB, Karanam A, Meador KJ, et al.

    JAMA neurology 2022; (79(4)):370-379 doi:10.1001/jamaneurol.2021.5487.

    PMID: 35157004
  23. 23

    AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies.

    Thangaratinam S, Marlin N, Newton S, et al.

    Health technology assessment (Winchester, England) 2018; (22(23)):1-152 doi:10.3310/hta22230.

    PMID: 29737274
  24. 24

    Dose adjustment of the anti-seizure medications levetiracetam and lamotrigine during the postpartum period. Schedule plan, safety and efficacy.

    Khmelev N, Fahoum F, Goldstein L

    Epilepsy & behavior : E&B 2026; (175()):110858 doi:10.1016/j.yebeh.2025.110858.

    PMID: 41389469
  25. 25

    The impact of pregnancy-related hormonal and physiological changes on antiseizure medications: expert perspective.

    Li D, Franco S, Pennell PB

    Expert review of clinical pharmacology 2024; (17(8)):655-663 doi:10.1080/17512433.2024.2356617.

    PMID: 38748860
  26. 26

    Management of reproductive risks in people with epilepsy.

    Bjørk MH, Cukiert C, Nucera B, Bromley RL

    The Lancet. Neurology 2025; (24(7)):601-613 doi:10.1016/S1474-4422(25)00130-9.

    PMID: 40541210
  27. 27

    Antiseizure Medications in Pregnancy.

    Moise AC, Gerard EE

    Obstetrics and gynecology clinics of North America 2023; (50(1)):251-261 doi:10.1016/j.ogc.2022.10.014.

    PMID: 36822708
  28. 28

    Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy.

    Birnbaum AK, Meador KJ, Karanam A, et al.

    JAMA neurology 2020; (77(4)):441-450 doi:10.1001/jamaneurol.2019.4443.

    PMID: 31886825
  29. 29

    Valproic acid concentrations in nursing mothers, mature milk, and breastfed infants in monotherapy and combination therapy.

    Kacirova I, Grundmann M, Brozmanova H

    Epilepsy & behavior : E&B 2019; (95()):112-116 doi:10.1016/j.yebeh.2019.04.002.

    PMID: 31035102
  30. 30

    Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force

    Tomson T, Battino D, Bromley R, et al.

    Epileptic disorders : international epilepsy journal with videotape 2022; (24(6)):1020-1032 doi:10.1684/epd.2022.1492.

    PMID: 36193017
  31. 31

    [Pharmacological treatment of women with epilepsy before and during pregnancy].

    Müffelmann B, Bien CG

    Der Nervenarzt 2016; (87(10)):1115-1126 doi:10.1007/s00115-016-0210-1.

    PMID: 27631817
  32. 32

    Concentrations of antiseizure medications in breast milk of lactating women with epilepsy: A systematic review with qualitative synthesis.

    Shawahna R, Zaid L

    Seizure 2022; (98()):57-70 doi:10.1016/j.seizure.2022.03.017.

    PMID: 35427849

This page is for informational purposes only and does not constitute medical advice. Do not start, stop, or change an anti-seizure medicine, contraceptive, or supplement without an individualized plan from your neurologist and obstetric care team.